Compounds > cetylpyridinium chloride anhydrous
Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and cyclic gmp

cetylpyridinium chloride anhydrous has been researched along with cyclic gmp in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kocsis, B; Kovács, T; Nagy, J; Schmelczer, M; Vas, T; Wagner, L1
Cockcroft, JR; Coffey, MJ; Coles, B; Lewis, MJ; Morrow, JD; O'Donnell, VB; Sanchez, S; Williams, PC1

Trials

1 trial(s) available for cetylpyridinium chloride anhydrous and cyclic gmp

ArticleYear
In vivo aspirin supplementation inhibits nitric oxide consumption by human platelets.
    Blood, 2005, Oct-15, Volume: 106, Issue:8

    Topics: Aspirin; Blood Platelets; Cyclic GMP; Dose-Response Relationship, Drug; Health; Humans; Isoenzymes; Nitric Oxide; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Thromboxanes; Time Factors

2005

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and cyclic gmp

ArticleYear
Effect of smoking on urinary NOx and cGMP excretion in IgA nephropathy and in health.
    Contributions to nephrology, 2000, Volume: 130

    Topics: Adult; Age Factors; Creatine; Cyclic GMP; Female; Glomerulonephritis, IGA; Health; Humans; Male; Nitrites; Smoking

2000